Idexx Laboratories (IDXX) EV to CFO (2009 - 2026)
Idexx Laboratories (IDXX) posted EV to CFO of 119.04 for Q2 2026, down 28.49% on a QoQ basis from 166.48 in Q1 2026, and down 48.37% year-over-year from 230.55 in Q2 2025.
Analysis
Idexx Laboratories (IDXX) EV to CFO (2009 - 2026) Analysis & Trends
Idexx Laboratories has reported EV to CFO for 18 years, with the latest figure at 119.04 in Q2 2026.
- On a quarterly basis, EV to CFO fell 48.37% year-over-year to 119.04 in Q2 2026; TTM through Jun 2026 was 30.13, a 36.26% decrease from a year earlier, with the FY2025 full-year figure at 45.48, up 26.31% from the prior year.
- EV to CFO was 119.04 for Q2 2026 at Idexx Laboratories, down from 166.48 in the prior quarter.
- The five-year high for EV to CFO was 442.62 in Q2 2022, with the low at 119.04 in Q2 2026.
- Average EV to CFO over 5 years is 197.78, with a median of 174.56 recorded in 2026.
- The sharpest annual moves came in 2022 and 2023: EV to CFO surged 93.52% in 2022, then slumped 53.1% in 2023.
- Over 5 years, EV to CFO stood at 194.35 in 2022, then declined by 6.02% to 182.64 in 2023, then tumbled by 30.1% to 127.66 in 2024, then advanced by 18.34% to 151.08 in 2025, then fell by 21.21% to 119.04 in 2026.
- The last three EV to CFO figures came in at 119.04 (Q2 2026), 166.48 (Q1 2026), and 151.08 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 42.23 Bn | 42.03 Bn | 779.09 Mn |
| 2 | Zoetis | 31.39 Bn | 29.72 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 12.21 Bn | 11.68 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.55 Bn | 1.47 Bn | 134.40 Mn |
| 5 | Immucell | 89.91 Mn | 81.05 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.30 Mn | 77.22 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 119.04 |
| Mar 31, 2026 | 166.48 |
| Dec 31, 2025 | 151.08 |
| Sep 30, 2025 | 126.52 |
| Jun 30, 2025 | 230.55 |
| Mar 31, 2025 | 141.80 |
| Dec 31, 2024 | 127.66 |
| Sep 30, 2024 | 186.92 |
| Jun 30, 2024 | 160.21 |
| Mar 31, 2024 | 223.32 |
| Dec 31, 2023 | 182.64 |
| Sep 30, 2023 | 132.11 |
| Jun 30, 2023 | 207.59 |
| Mar 31, 2023 | 225.09 |
| Dec 31, 2022 | 194.35 |
| Sep 30, 2022 | 142.54 |
| Jun 30, 2022 | 442.62 |
| Mar 31, 2022 | 399.61 |
| Dec 31, 2021 | 264.50 |
| Sep 30, 2021 | 281.20 |